Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Wright

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Human Genetics : EJHG|May 20, 2026
Systematic mapping of rare genetic disease studies using UK primary care electronic health recordsThomas E B Wright, Hannah Slevin, Sinéad Magnier, et al.
AIDS Research and Human Retroviruses|December 15, 2015
CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenCarola R Röhrich, Britt I Drögemöller, Ogechi Ikediobi, et al.
The Lancet. Neurology|October 25, 2020
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapiesGalen E B Wright, Hailey Findlay Black, Jennifer A Collins, et al.
Pharmacogenomics|August 6, 2015
Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohortTyren M Dodgen, Britt I Drögemöller, Galen E B Wright, et al.
Clinical Pharmacology and Therapeutics|July 13, 2018
Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy GenesGalen E B Wright, Ursula Amstutz, Britt I Drögemöller, et al.
Breast Cancer Research and Treatment|November 10, 2018
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelinesBritt I Drögemöller, Galen E B Wright, Joanne Shih, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 19, 2012
Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohortGalen E B Wright, Dana J H Niehaus, Lize van der Merwe, et al.
Clinical Pharmacology and Therapeutics|April 24, 2019
Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of ResearchBritt I Drögemöller, Galen E B Wright, Cody Lo, et al.
Pharmacogenomics|January 22, 2014
Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patientsBritt I Drogemöller, Dana J H Niehaus, Bonginkosi Chiliza, et al.
Frontiers in Neurology|September 24, 2021
Integrative Neuroinformatics for Precision Prognostication and Personalized Therapeutics in Moderate and Severe Traumatic Brain InjuryFrederick A Zeiler, Yasser Iturria-Medina, Eric P Thelin, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Human Genetics : EJHG|May 20, 2026
Systematic mapping of rare genetic disease studies using UK primary care electronic health recordsThomas E B Wright, Hannah Slevin, Sinéad Magnier, et al.
AIDS Research and Human Retroviruses|December 15, 2015
CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenCarola R Röhrich, Britt I Drögemöller, Ogechi Ikediobi, et al.
The Lancet. Neurology|October 25, 2020
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapiesGalen E B Wright, Hailey Findlay Black, Jennifer A Collins, et al.
Pharmacogenomics|August 6, 2015
Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohortTyren M Dodgen, Britt I Drögemöller, Galen E B Wright, et al.
Clinical Pharmacology and Therapeutics|July 13, 2018
Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy GenesGalen E B Wright, Ursula Amstutz, Britt I Drögemöller, et al.
Breast Cancer Research and Treatment|November 10, 2018
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelinesBritt I Drögemöller, Galen E B Wright, Joanne Shih, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 19, 2012
Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohortGalen E B Wright, Dana J H Niehaus, Lize van der Merwe, et al.
Clinical Pharmacology and Therapeutics|April 24, 2019
Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of ResearchBritt I Drögemöller, Galen E B Wright, Cody Lo, et al.
Pharmacogenomics|January 22, 2014
Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patientsBritt I Drogemöller, Dana J H Niehaus, Bonginkosi Chiliza, et al.
Frontiers in Neurology|September 24, 2021
Integrative Neuroinformatics for Precision Prognostication and Personalized Therapeutics in Moderate and Severe Traumatic Brain InjuryFrederick A Zeiler, Yasser Iturria-Medina, Eric P Thelin, et al.
Pageof 7